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Abstract 
 
 
Main Idea:  
Analysis of the evolution of quality of life (QoL) of patients with spinal cord injury (SCI) throughout the 
clinical trial STImulation of Movement Overground (STIMO) with spinal epidural electrical stimulation (EES) 
in combination with Robot-assisted neurorehabilitation. ClinicalTrials.gov Identifier: NCT02936453.  
 
Introduction:  
As already cited in the STIMO protocol, SCI patients usually have a diminished QoL.  
This new therapy, by EES in combination with a robot-assisted neurorehabilitation, being tested for the very 
first time in humans will enhance the ability to stand and walk which has an impact on these patients’ day to 
day living as the increased independence in activities of daily living is a key point in the QoL index. The study 
only takes into consideration objective test values obtained in the walking laboratory, and excludes the global, 
subjective changes in day to day living. An evaluation pertaining specifically to patients with spinal cord 
injury, more precise and detailed than at STIMO study initiation, therefore seems to be a significant addition. 
 
Objective:  
To put in place a more detailed and effective system for the evaluation of QoL of STIMO trial patients. To 
enable a more in-depth analysis that goes further than the SF-36 questionnaire that is used in the original 
protocol.    
 
Method: 
A subjective, specific and internationally recognized questionnaire, the WHOQOL-Bref was added to the study 
at the following timepoints: pre-rehabilitation, intermediate, post-rehabilitation, 3-months extension, 6-month 
extension. Analysis of functional independence with the SCIM III at pre-rehab, intermediate, post-rehab and 
both extensions. Analysis of the evolution of HRQoL with the SF-36 at pre-implantations, pre-rehabilitation, 
post-rehabilitation and 6-months extension.   
 
Expected results:  
Concurring with the expected results of the STIMO trial, we hope to obtain an improvement in the patients’ 
QoL. We hypothesize that there will be a correlation between the objective values obtained in the walking lab 
of functional independence evaluated with the SCIM III questionnaire and of health-related QoL obtained 
through the SF-36 questionnaire, and the subjective values in the patients’ everyday environment evaluated 
with the WHOQOL-Bref survey.   
 
Added value:  
This analysis will add a more thorough and detailed dimension to the evaluation of the QoL, including more 
parameters than just the ability to move and walk during the experiment. It will take into consideration the 
psychological, social, environmental point of view of the patient. In the end, these values that influence the 
patients’ day to day living are significant for the end results of the trial.  
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Introduction 
 
Spinal cord injury (SCI) is a life-changing damage to the spinal cord that was considered a terminal condition 
in previous generations. In recent years, however, mostly in high-income countries, medical advancement such 
as better first response care, rehabilitation treatments and assistive devices, has made its mortality rates 
stabilize and slowly diminish. (1,2) More SCI patients are able to survive the acute phase directly following 
the trauma and have to adapt to a chronic stage of SCI which necessitates a more personal, social, and 
environmental adjustment. Note that all these above stated items have an important influence on an individual’s 
quality of life (QoL).  
 
Spinal Cord Injury Epidemiology 
SCI data in literature is sparse making worldwide prevalence, incidence and demographics studies difficult to 
evaluate. (2,3) Spinal cord injuries are separated into two categories: nontraumatic spinal cord injury (NTSCI) 
which is SCI that is not caused by an external trauma but rather by internal causes such as cancer, infection, 
ischemia, inflammatory or congenital disease, or metabolic disorders for instance(4) and traumatic spinal cord 
injury (TSCI). Current literature mostly concentrates on TSCI making NTSCI data hard to find. Furthermore, 
the STIMO study’s patients are all TSCI individuals. We will, therefore, concentrate on TSCI demographics.  
Prevalence is defined as the number of people in the population living with SCI at a given time point and is 
influenced by the existing risk factors and time span of a condition. A proper evaluation of SCI prevalence 
would allow the further development of SCI prevention. In a 2013 WHO’s analysis, traumatic spinal cord 
injury (TSCI) worldwide prevalence ranged from 280 per million population in Finland to 1298 per million in 
Canada. [see table 1]. These excessive variations are probably due to differences in methodology according to 
the study along with variation in prevention and safety from one country to another.   
 
Table 1. Prevalence of TSCI. Source: (2).  Figure 1. Global variation in country-level 
------------------------------------------------------------------------ estimates of annual incidence of TSCI.  
     Source: (2).   
---------------------------------------------------- 
------------------------------------------------------------------------- 
 
        ---------------------------------------------------- 
Incidence corresponds to the number of people who have suffered a SCI in a given population over a given 
period of time, generally per year. Global SCI incidence seems easier to estimate than prevalence at 
approximately 40 to 80 new cases per million population per year. This global incidence is based on country-
level incidence studies from all causes of SCI with similar and accepted methodologies. This means 250 000 
to 500 000 SCIs occur every year. More specifically, TSCI incidence rates vary from 13 per million population 
in the Netherlands to 53 cases per million population in Canada.(2) [see Figure 1]. A few trends can be 
perceived from incidence analysis in these different countries. Incidence rates for male adult TSCI are almost 
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double the incidence rate of female adults worldwide.(1–3) In a few studies, the ratio is even higher; in Ireland 
and Brazil for instance the ratio is >5:1. (5,6) Also, two main time peaks in age are seen for TSCI : young 
adults (16 to 30 years old) probably due to a higher chance of work related or road accidents and the elderly 
(> 60 years old) due to a higher chance of falls. If we take the United States as an example, falls in individuals 
aged 65 years or older in 1997-2000 represented 28% of SCI whereas in 2010-2012 represents 66%. (7) 
The expansion of human activity over the years plays an important role in the increase in incidence and 
prevalence of SCI in the population.(1)  
 
The three most common etiologies of TSCI are as follows and in this order of frequency: road traffic accidents, 
falls and violence (self-harm included). These causes are more or less frequent depending on the country. [see 
figure 2] Falls are becoming the number one cause in the aging-population which explains the second age peak 
seen in incidence rates (> 60 years old). Although falls are quickly equalizing with road traffic accidents in 
developed countries, motor vehicle accidents are still the main cause of TSCI in non-developed countries. (1,3) 
 
Figure 2. Distribution of TSCI by WHO region. Source : (2). 
----------------------------------------------------------------------------------------------------------------------------------- 
 
----------------------------------------------------------------------------------------------------------------------------------- 
In SCI individuals, the risk of mortality depends on the level and severity of the injury. Individuals with higher 
and complete lesions will have a lesser chance of survival. (2) Life expectancy of individuals with SCI firmly 
depends on improvement in SCI diagnosis, emergency care units, general clinical care and development of 
better rehabilitation techniques. (1) It can be seen in demographics analysis that individuals with SCI in high-
income countries who can afford such care have a decreased mortality risk from secondary health conditions. 
The main causes of death in high-income countries for the spinal cord injured population are respiratory 
diseases like pneumonia and influenza and circulatory system diseases, which are all problems similar to those 
of individuals without SCI and not secondary to SCI. Still, individuals with SCI worldwide die before and 
more frequently than the general population.(1)    
The cost of SCI goes hand in hand with life expectancy and mortality. Parallelly, it depends on the level and 
severity of the injury, the timeline of treatment needed (the length of time in the hospital and the onset of 
secondary health conditions (SHCs)), direct medical costs for assistive devices for instance and indirect costs 
linked to individual productivity loss. A patient with a higher lesion (tetraplegia), complete lesion, with more 
SHCs and who is less productive for society will cost more.(2)  
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SCI Epidemiology in Switzerland  
In Switzerland, the Swiss Spinal Cord Injury (SwiSCI) Cohort study is the main platform used for estimating 
TSCI demographic evolution. The data is representative of the Swiss population as a whole and is given 
following demographic and characteristics specific to SCIs. In this data, the conclusions drawn are similar to 
worldwide incidence deductions. Out of 932 cases, 239 were female versus 693 males putting the female-male 
ratio at 1:3. This result is similar to the average global ratio which is superior to or equal to 1:2. Just like in 
most countries, there are less cases of complete lesion than cases of incomplete lesion and the leading causes 
of TSCI are falls (aging-population) and sports or leisure-related injuries for both males and females. The 
average age for TSCI is 48.0 years old. In Switzerland from 2005 to 2012, the total annual incidence rate for 
TSCI was 18.0 per million which is slightly higher than global overall annual incidence rate but intermediate 
when compared to other countries. [see figure 3]. One difference with general global demographics is that 
paraplegia (affecting inferior limbs) is more common than tetraplegia (affecting all four limbs) in 
Switzerland.(8)  
 
Figure 3. European estimates of annual TSCI incidence per million population. Comparison of reported 
annual incidence rates per million population for European countries with similar methodology. Source:(8). 
---------------------------------------------------------------------------------------------------------------------------------    
 
----------------------------------------------------------------------------------------------------------------------------------- 
QoL in SCI patients  
Following a SCI, the body fights to recover the functions that have been lost. Many severe impairments in 
bladder, bowel, cardiac, respiratory, sensory and sexual function occur. Be it locomotion, sphincter control, 
sexual dysfunction, autonomic dysfunction, all these secondary complications, acute and chronic, have an 
important effect on the individual’s QoL. The patient struggles with day to day activities and needs time for 
adjustment and a coping process. Not surprisingly, people with SCI tend to report a lower QoL than non-
disabled individuals.(9)     
 
Defining QoL in SCI is not easy. Many different aspects must be taken into consideration. One definition given 
by the WHO is: "an individual's perceptions of their position in life in the context of the culture and the value 
systems in which they live, and in relation to their goals, expectations, standards and concerns".(10) Other 
studies define it as ; “the sum total of the cognitive and emotional reactions that people experience when they 
compare what they have and do in life with their aspirations, needs, and other expectations” (11). Throughout 
literature, one precise and repeated definition is hard to find. This existing lack of consensus makes it difficult 
to find harmony on how to measure QoL and follow its evolution over time. The QoL concept is one of the 
most controversial medical, rehabilitative, social and psychological constructs dealt with in clinical 
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research.(11) It can include the person’s physical health and level of functioning but also a person’s 
psychological well-being, happiness, the individual’s current life situation and satisfaction, social participation 
and response to the environment. (12,13) Individuals each value different aspects of life. QoL seems to be an 
extremely subjective experience likely influenced by cognitive factors.(9,13) Only quantifying it through 
objective measurements, as it is frequently done in literature, doesn’t seem judicious.(14) Frequently, an 
inconsistency is seen between clinical measures and the patient’s individual assessment of health.(15) A 
distinction must be stressed between objective and subjective QoL which turn out to be two different 
approaches to QoL. One is considered a rather medical/somatic approach and the second, a rather 
psychological approach. (16) What complicates the concept of QoL is that both these approaches interact one 
with the other. As seen in Figure 4 of Tramonti et al 2014 below (12), health-related QoL (HRQoL) cannot be 
interpreted without functional statuses allowing evaluation of physical function but individualized QoL and 
evaluation of mental health must also be included. Correlations between these elements must be seen as a 
continuum. (12) As stated in Megari et al 2013, “in sum, QoL is inherently a dynamic, multilevel and complex 
concept, reflecting objective, subjective, macro societal, and micro individual, positive and negative influences 
which interact.”  
 
Figure 4. Pattern of associations among different measures of QoL and functional status. Source:(12). (Here 
replace SEIQoL-DW not used in our study with the WHOQOL-Bref.)  
----------------------------------------------------------------------------------------------------------------------------------- 
 
----------------------------------------------------------------------------------------------------------------------------------- 
Objective QoL 
The most frequently used definition of QoL, (the one usually referred to in clinical trials when QoL is not 
clearly defined) is objective Qol, also referred to in literature as HRQoL or “QoL as utility” following the 
Dijkers model of QoL.(11) HRQoL can be defined as course of life altered by “impairments, functional states, 
perceptions and social opportunities”.  Often, researchers divide HRQoL into specific life domains: physical, 
psychological and social functioning in regards to disease or treatment. This means HRQoL refers to the extent 
to which illness, injury, or treatment can influence the individual’s experience of life. (12,13,17) Indeed, many 
SCI research uses this ‘definition’ of QoL when evaluating it. HRQoL measurements lack the overall 
sensitivity to reflect change and note a difference in evolution between people with SCI. Interindividual 
differences in perception and expectations are not addressed in SCI research. In evaluating new technology, 
treatment and rehabilitative methods, it seems important to incorporate measures of QoL that take into 
consideration the significance each such domain has for the SCI individual. (11–13,18)    
 
Subjective QoL 
Subjective Qol, frequently referred to as individual QoL “QoL as subjective well-being”(11) and finally 
“patient centered evaluation of Qol”(12), is a personal evaluation of life satisfaction based on specific domains 
that are considered more important to the individual. What stands out in subjective QoL is known as “domain 
importance”. The usual domains that contribute to overall QoL as seen above included in HRQoL (physical, 
psychological and social functioning, material well-being…) have a different inter-individual value which 
must be assessed. Evolution in satisfaction in a domain that scores extremely high on the individual’s scale of 
domain importance will have much greater impact than improved satisfaction within a lesser domain.(12,18–
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20) The psychological domain, mentioned above, is especially patient centered. Self-control, self-worth, self-
esteem, self-purpose and hope, optimism along with low posttraumatic cognition and high affects are all 
positive psychological factors considered to be determinant in QoL literature.(21) In recent research, these 
personal factors stood out to explain a significant amount of discrepancy in life satisfaction. (12,22) In SCI 
QoL measurements, subjective domain importance must imperatively be taken into consideration to avoid 
giving equal importance to evolution of specific domains. However, the word ‘subjective’ in research is usually 
negatively connotated as non-objectifiable and could be more complicated to evaluate.(13)     
 
Secondary Health Conditions 
A secondary health condition (SHC) is defined by the Institute of Medicine as : “a condition that is causally 
related to a disabling condition (that is, occurs as the result of a primary disabling condition and that can either 
be a pathology, an impairment, a functional limitation or an additional disability)”. (23) In SCI, SHCs are 
extremely frequent and considered key determinants in the evolution of the disability, mortality, life 
expectancy and well-being.(24) 95% of SCI individuals experience one or more of these conditions.(25,26) 
Six of these SHCs stand out regarding frequency (reported prevalence of over 50%) and effect on the SCI 
individuals life : spasticity, chronic pain, bladder and bowel problems, sexual dysfunction and sleep. (14–17) 
[see figure 5.a.] These findings are in agreement with results from SwiSCI cohort in Switzerland. As seen in 
Brinkhof et al 2016’s figure [see figure 5.b.], in Switzerland, sexual dysfunction, sleep and spasticity are three 
chief SHCs that patients report as significant or chronic and more importantly that report that aren’t receiving 
treatment for.(24) Both quadriplegics and paraplegics rate these conditions as important concerns and 
furthermore, say they have difficulty dealing with them.(9)   
Constant or daily pain that lasts more than three months is termed chronic pain. Up to 80% of individuals with 
SCI experience chronic pain which mainly includes musculoskeletal, neuropathic and visceral pain.(31,32) 
Many studies draw a parallel between chronic pain and lower psychological functioning along with diminished 
QoL. (31–34)  
Spasticity is experienced by 70% of all SCI individuals following the first year after the injury. It refers to 
muscles spasms and clonus along with a rise in muscle tone and exaggerated tendon reflexes. (34,35) Slight 
spasticity can be advantageous to SCI individuals but the severe spasticity usually experienced causes pain 
and decreases QoL.(36,37) Spasticity is also related to sleep problems, fatigue and bladder dysfunction, all 
elements that SCI individuals are very effected by on a daily basis.(38)     
Bladder problems in SCI include incontinence, bladder or kidney stones, kidney malfunction, urine leakage or 
urine backup and kidney or bladder infections. Bowel disorder in SCI is widely due to neurogenic bowel. This 
leads to diarrhea or constipation, ‘accidents’, and visceral pain. (24) These bowel and bladder dysfunctions 
severely influence many aspects of QoL, especially social and psychological. For instance, on a social 
viewpoint, reintegrating society and maintaining relationships is made more difficult when controlling bowel 
movements and avoiding urine leakage are major concerns.  
Sexual health is defined as: “a state of physical, emotional, mental, and social well-being in relation to 
sexuality; it is not merely the absence of disease, dysfunction, or infirmity”.(69) For instance, decreased 
sensation, difficulty in movement and problems with bowel and bladder control in patients with SCI can lead 
to dissatisfaction with sexual functions. Sexual function is the most frequent problem that isn’t treated or 
enough evoked by health care professionals according to SCI individuals. (24) Individuals with paraplegia rate 
regaining sexual function as their highest priority to improve QoL. (9) 
In many studies, neurologic disorders have proven to significantly compromise sleep. In SCI, sleep disorders 
seem to have an important effect on QoL. Disrupted sleep leads to increased pain, spasticity and mostly fatigue 
which has an important psychological effect on SCI individuals. (39)  
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Figure 5.a. Prevalence of reported health condition problems and existing diagnoses. 95% CI: 95% interval. 
5.b. Rates of reporting non-treatment for health conditions (HCs) of significant or chronic severity (SCI-SCS, 
level 3, Appendix 1).  Both from source:(24).    
----------------------------------------------------------------------------------------------------------------------------------- 
a.                                                                                     b.  
        
----------------------------------------------------------------------------------------------------------------------------------- 
Socially, psychologically, physically and financially, these 6 SHCs diminish SCI individuals’ life satisfaction 
and emotional well-being. (24) QoL of SCI patients is highly influenced by the manifestation of these health 
conditions. These must be included in defining it. (9)  
Other factors also influence QoL in SCI patients : age at injury, time since injury, level of lesion, low 
functional independence, social support, financial status. (34) Most of these factors are stable and constant 
meaning they do not influence evolution of QoL with time. Regaining some movement or function can lead to 
increased independence and is linked to increased QoL of individuals with SCI. (24,40) SHC have a higher 
impact on SCI individuals subjective QoL. In Rivers et al’s 2018 study, health conditions had a greater effect 
than functional independence. (30) 
 
Minimal clinically meaningful difference (MCID) 
Taking into consideration all of the aspects that make up the complex concept of QoL, broad clinical evaluation 
is far from simple. (11) In literature, the minimal clinically meaningful difference refers to the smallest 
variation in a score considered clinically important. This means “the smallest difference in score in the domain 
of interest which patients perceive as beneficial and which would mandate, in the absence of troublesome side 
effects and excessive cost, a change in the patient’s management.”(41,42) When this concept is applied to QoL 
measurements, an absolute minimum is risky to identify and can easily oversimplify the measurement. MCID 
in QoL are many times clinically relevant but statistically irrelevant. In a study by Barber BL et al, it was 
shown that patients that perceived minor improvements in their asthma considered these minimal changes 
important, but being too small, were not reflected.(43) In QoL survey’s, MCID’s are not definable and not 
used. Researchers are faced with two main problems when defining a MCID for QoL measurements. The 
direction of the evolution can have an effect on the meaning of the change. A positive increase could have a 
different impact than an equal value negative decrease. The meaning of change depends on the individual 
patient’s baseline of perceived health. A patient with more room for change will show a more important 
evolution be it negative or positive evolution. The evolution of patients closer to a high score on the QoL 
evaluation would be more difficult to identify. This is known as “celling (high scores) or floor effects(low 
scores)”(42).   
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Adaptation and response shift 
Initially, directly following a spinal cord injury, overall QoL drops due to the drastic reduction of satisfaction 
in important life domains and the feeling of loss of control over the individual’s life caused by the debilitating 
injury.(44) This drop will depend on the severity of domain affected and domain importance. Time in SCI and 
most of all in QoL for SCI individuals is essential.(45) SCI patients go through an initial acute phase from the 
time of the injury to approximately 1-year post injury. In this phase, neuro-rehabilitation is essential to allow 
recovery of motor function. Adaptation to the new situation usually starts taking place.(44) With time, the SCI 
is considered chronic. The patient reaches a limit and motor progression is more difficult. SHCs become more 
predominant in regard to QoL. SCI becomes a chronic condition with heavy physical and emotional costs. 
Individuals with SCI experience its consequences on a long period of time driving them to adapt and adjust to 
this condition. Individuals with lower QoL constantly seek to gain QoL points and reach their desired QoL 
level.(12,46) Adaptation is vital to living with SCI and coping mechanisms are a major focus in current 
rehabilitation.(47) This accommodation to a chronic condition is known as “response shift” and plays an 
important role in the evaluation of subjective QoL.(15) Response shift is defined in literature as : “a change in 
the meaning of one’s self evaluation of a target construct as a result of a change in the respondent’s internal 
standards of measurement or scale recalibration”.(13) Individuals will repeatedly experience secondary health 
conditions (SHCs) with time, adapt to these SHCs which means these SHC won’t impact their self-evaluation 
of QoL as much as they would have in a more acute situation. Response shift seems to be a good explanation 
as to why life satisfaction in patients who have lived longer with SCI tends to be effected less negatively by 
the occurrence of health conditions. (28) Frequently observed positive factors to psychological adjustment in 
SCI are age and time since injury.(48) Not all measures are affected equally by response shift. Less the concept 
of the measurement is concrete and objective, more it will be affected by response shift. In evaluating 
functional independence, response shift will not have an effect. The individual can or cannot walk 500m. His 
or her perception is not taken into consideration. As seen previously, the evaluation of QoL is subjective and 
it’s definition variable throughout literature making it very prone to response shift.(13,49) To obtain a valid 
and sensitive evaluation of evolution of QoL over time, the effect of response shift should be taken into 
consideration. (15)  
Once an individual has undergone response shift, meaning he or she has created coping strategies and adapted 
to a situation, changing the baseline reached is difficult. Positive events and evolution are harder to bring to 
light in the evaluation of QoL. Once established in chronic injury, QoL is hard to change. Chronic SCI 
individuals’ QoL with time tend to reach similar values than general population’s QoL. (50)  
 
Introduction to the STIMO study  
In recent literature, only few clinical trials or rehabilitative techniques have shown advancement in recovering 
the ability to walk or stand after SCI. Electrical stimulation of muscles, epidural and intraspinal electrical spinal 
cord stimulation has been tested in order to assist SCI patients in verticalization and getting back on their 
feet.(1,51,52) Locomotion in SCI patients is noticeably eased by epidural electrical stimulation. These 
stimulations help induce plastic changes in sensorimotor circuits below injury directly affecting stepping 
pattern over time. Courtine et al. was able to show that the combination of lumbo-sacral pharmacological and 
electrical spinal stimulation after a week in rodents that had undergone a complete spinal cord lesion, 
transformed their medullar pathways from non-functional to highly functional. Stimulation in combination 
with intensive rehabilitation training permitted rodents to recover full ‘voluntary stepping-like’ hindlimb 
locomotion with assistance for balance. (53) In humans, reorganization of sensorimotor circuits happens 
spontaneously following incomplete spinal cord injury and is highly influenced by neurorehabilitation. This 
reorganization usually reaches an unsurpassable threshold. The STIMO study or Efficacy of Spinal Epidural 
Electrical Stimulation (EES) in combination with Robot-assisted neurorehabilitation in individuals with Spinal 
Cord Injury Study, a safety and feasibility study, was developed to facilitate recovery of locomotion in chronic 
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incomplete spinal cord injured patients. Combined with a body-weight support system that enables over-
ground walking for motor training, the stimulation improves locomotion when activated but also in the long 
run without activation.(54) Recently, a proof-of concept has been validated in three male individuals with 
chronic cervical SCI leading to sever lower limb deficit or complete paralysis. Indeed, this combined 
technology has improved and restored standing and walking capacities in these patients. (55) Functional 
improvement facilitates these patient’s ability to get around and ease day to day activities that had been 
compromised by loss of motor function. It seems important to evaluate these patient’s QoL over the time of 
the study in order to see how significant the effect of this therapy can be. Could the improvements in motor 
function demonstrated in STIMO be sufficient to have a quantifiable and significant impact on these 
individuals’ QoL?   
 
Hypothesis 
The improvement of motor function gained through the STIMO trial will affect SCI patient’s QoL.  
 
Study design  
The STIMO study is a monocentric prospective pilot study divided into three stages [as seen in Figure 6]. The 
main study during rehabilitation takes place in the STIMO Gait laboratory at the Centre Hospitalier 
Universitaire Vaudois (CHUV) with assessment at the Balgrist University Hospital Spinal Cord Injury Center 
and lasts about 5 to 6 months for each single case. An optional study extension with home use of the devices 
for neurorehabilitative training with EES lasts a minimum 3-year period. 
 
Figure 6. STIMO study timeline. Source: (55).  
----------------------------------------------------------------------------------------------------------------------------------- 
 
------------------------------------------------------------------------------------------------------- 
 
Test subjects 
This QoL study includes 3 SCI subjects, all males included in the STIMO study. The STIMO study will enroll 
N=8 subjects with chronic (>12 months after date of injury), incomplete SCI. Inclusion criteria are: age 18 to 
65 years old (women or men); incomplete SCI graded as American Spinal Injury Association (ASIA) 
Impairment Scale (AIS) C and D, level of lesion T10 or above with preservation of conus function, intact 
distance between the cone and the lesion must be at least 60mm; focal spinal cord disorder caused by either 
trauma or epidural, subdural or intramedullary bleeding; minimum 12 months post-injury, completed in-patient 
rehabilitation program (must be aware of functional limitations); able to stand with walker or two crutches; 
adequate care-giver support and access to appropriate medical care in individuals’ home community. The 
individual must be clinically stable (the individual has attained a plateau at which no further functional 
improvements can be reached) and most importantly psychologically ready to undergo an intensive 
neurorehabilitative training (STIMO protocol version 1.2). Exclusion criteria include : motor functions limited 
by additional disorders (systemic malignant, cardiovascular, peripheral nerve disorders); history of significant 
autonomic dysreflexia; brain damage; epilepsy; patients with baclofen pumps, active implanted cardiac device, 
with an indication to diathermy, who would require MRI, with increased risk of defibrillation, with restricting 
lower limb movements from severe joint contractures, with hematological disorders, who are participating in 
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another locomotor training study, with known or suspected non-compliance, drug or alcohol abuse; women 
who are pregnant; congenital or acquired lower limb abnormalities; non-traumatic spinal cord lesion; patient 
could be limited in investigator’s opinion; patients whose life expectancy is less than 12 months.    
 
Method  
In the original STIMO protocol (version 1.2), the SF-36 survey was the only questionnaire dedicated to 
evaluating QoL throughout the study as a means to evaluate the healthcare being provided. This questionnaire 
is referred to as a generic measurement of the state of health by assessing eight health domains: limitations in 
physical functioning (PF), limitations of role due to physical health (RP), bodily pain (BP), general health 
(GH), vitality and fatigue (VT), limitations of role due to emotional problems (RE), social functioning (SF), 
and mental health or emotional well-being (MH). These eight domains can be divided into two entities: the 
physical component score (PCS) and the mental component score (MCS). The PCS includes: high scores of 
PF, RP, BP and GH and low scores on the RE and MH. Inversely, the MCS is in relation with high scores on 
the MH, RE, SF and VT scales and low scores of the PF and RP scales. The questions are scored on a 1 to 6 
scale depending on the question. Each score obtained must first be recoded using the values as seen in table 
2.A. The sub-scales are created by averaging the question scores as seen in table 2.B. This makes up what is 
referred to as the transformed scores for each sub-scale. For the general population, the normative value of the 
mean score is 50 for each of these eight domains with a normative value of the standard deviation at 10. (SF-
36 scoring instruction RAND); (56,57)      
 
Table 2. Scoring instructions to obtain the SF-36 transformed scores. A. Recoded values depending on original 
response for each the item. B. Items to average to obtain each sub-scale score. Source: SF-36 scoring 
instructions RAND.   
----------------------------------------------------------------------------------------------------------------------------------- 
A.                                                                                                            B.    
   
----------------------------------------------------------------------------------------------------------------------------------- 
In terms of validity in the SCI population, the SF-36 is frequently used.(56) A few issues do however exist in 
reference to SCI individuals: three questions that refer to walking and climbing stairs are not applicable for 
patients who may use a wheelchair to move. Floor effects or compressed scale ranges could be more frequent 
in using this survey in the SCI population because it doesn’t distinguish between the general population and 
the disabled population. (58)  
 
The first addition to the STIMO study questionnaires (protocol version 1.10) was to the WHOQOL-Bref 
(World Health Organization Quality of Life- Bref) questionnaire. This allowed a more sensitive and subjective 
QoL analysis as well as more specific to SCI that was not available to us with the generic and objective SF-
36. The WHO has established an international, cross-cultural and cross-population definition of QoL. In an 
attempt to generify the measure of QoL, the WHOQOL-100 was first created and summarized into the 
WHOQOL-Bref which contains 26 questions. There is a high correlation (0.89 or more) between the domain 
scores produced from both these surveys. (45,59) The WHOQOL-Bref was developed to help health 
Item 
number
Original 
response
Recoded 
value
Original 
response
Recoded 
value
Original 
response
Recoded 
value
Original 
response
Recoded 
value
Original 
response
Recoded 
value
Original 
response
Recoded 
value
1 100 1 0 1 0 1 100 1 0 1 0
2 75 2 50 2 100 2 80 2 20 2 25
3 50 3 100 3 60 3 40 3 50
4 25 4 40 4 60 4 75
5 0 5 20 5 80 5 100
6 0 6 100
32,33,351,2,20,22,34,36 3,4,5,6,7,8,9,10,11,12 13,14,15,16,17,18,19 21,23,26,27,30 24,25,28,29,31
Health 
concept
Number 
of items
Items to average
PF 10 3,4,5,6,7,8,9,10,11,12
RP 4 13,14,15,16
RE 3 17,18,19
VT 4 23,27,29,31
MH 5 24,25,26,28,30
SF 2 20,32
BP 2 21,22
GH 5 1,33,34,35,36
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professionals in evaluating the efficacy of treatments in clinical trials. It analyses QoL divided into 4 domains 
which are as follows and detailed in Table 5: physical health, psychological health, social relationships and 
environment. In each of these domains and overall, a higher score equals a higher QoL. Scores are initially on 
a 1 to 5 scale and transformed to a 1 to 100 scale. The WHOQOL-Bref has been validated for use in clinical 
trials including SCI individuals. The domain scores have a good discriminant and content validity as well as 
good internal consistency and test-retest reliability.(59,60)  
In Lude et al 2014’s longitudinal multicentered study of QoL throughout SCI rehabilitation, the WHOQOL-
Bref was used and assessed. Lesion level and lesion type had a clear influence on results especially in the 
physical domain. Another element that affected the physical domain but also had an influence on 
psychological, social relationships and environment was time (be it 6 weeks to 2 years post injury). As seen in 
figure 8., all domain scores increase with time. The lesser effect of physical impairment on QoL influenced by 
adjustment with time to the disability in shown. At the 4th time point in Figure 8, all SCI individual’s 
WHOQOL-Bref scores tend to reach general population scores.   
 
 
 
 
Table 5. WHOQOL-Bref domains. Source: 
(WHOQOL-Bref scoring instructions) 
Figure 8. Mean WHOQOL-Bref scores for each 
domain at 6 weeks, 12 weeks, 1 year and 2 years 
post injury the participants (Lude et al. 2014) with 
spinal cord injury for (SCI) and the close persons, 
with the mean values in the general population as 
a reference. Source:(50) 
----------------------------------------------------------------------------------------------------------------------------------- 
 
----------------------------------------------------------------------------------------------------------------------------------- 
Already included in the study, in order to access functional independence was the SCIM III (Spinal Cord 
Independence Measure III). The SCIM III consists of 19 items divided into 3 subscales which include self-
care, respiration and sphincter management and mobility. The maximum score is 100 meaning the closer the 
individual is to 100 points, the less assistance in basic activities of daily living he will need.(61) This disability 
scale was designed particularly for SCI patients and has been repeatedly validated and considered reliable in 
multi-cultural, multi-centered studies.(62–64) Through this evaluation, the individual´s function and 
performance in daily activities is weighed. To date, SCIM III is the most sensitive functional independence 
questionnaire in literature in regards to change. Many functional independence surveys exist. For instance, 
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FIM (Functional Independence Measure) is a widely-known and validated questionnaire, but the SCIM III, a 
SCI-tailored survey, reaches higher sensitivity making it more valuable for the STIMO study.(62,64,65)  
After studying the close relationship between SHCs and QoL. We chose to add specific questionnaires 
assessing sleep (Sleep Quality Assessment PSQI), spasticity (The Spinal Cord Injury Spasticity Evaluation 
Tool - SCI-SET), bladder and bowel control problems (clinical evaluation in bladder function and the 
Neurogenic Bowel Dysfunction Score), and sexuality (International Index of Erectile Dysfunction). We use 
already included questionnaires SPA (Short Pain Assessment) for pain and SCIM III (Spinal Cord 
Independence Measure III) for functional independence. This questionnaires set is assessed at three time 
points: before the start of the study, post-rehabilitation and 3 months into the STIMO extension study. One 
exception is the questionnaire on sex life which is evaluated yearly. The EQ-5D-5L and the Reintegration to 
Normal Living Index (RNLI) were later added for more specificity in general QoL evaluation, an assessment 
of the evolution of social participation and because these questionnaires are required in order to obtain 
reimbursement of new therapies being the standard benchmark for QoL in health economics. During the 
STIMO extension study, all questionnaires are assessed as a digital survey.    
Limitation of some QOL questionnaires are questions that are not adapted to SCI patients (questionnaires about 
walking distances more than 1km, or running). We did our best to avoid such questionnaires.    
What will be interesting in this QoL analysis will be comparing objectified values of functioning (ex. SCIM 
III) with QoL evolution (both objective and subjective).  
 
Results 
The low number of data points collected at this stage of the study execution and the low number of subjects 
included in the study will only allow comments on possible trends.  
 
HRQoL Measurements 
In STIMO, the SF-36 questionnaire was used at the following four timepoints: pre-implantations, pre-
rehabilitation, post-rehabilitation and extension at 6-months (M6) to evaluate HRQoL of our patients. The 
results are shown in figure 7. 
 
Figure 7. Transformed scores for the 8 domains of the SF-36 survey for patients 1,2,3 at four timepoints 
throughout the STIMO study: pre-implant, pre-rehab, post-rehab and extension (M6).  
----------------------------------------------------------------------------------------------------------------------------------- 
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Physical Functioning (PF)  
Throughout the study, in the physical functioning (PF) domain of the SF-36, none of the patients surpass the 
40% score or show much variation in this domain. Three different behaviors are observed. Patient 1 shows a 
gradual decrease to an unanticipated final score of 0%.  Patient 2’s score is stable at 15% with a transitional 
doubling in score at post-rehab. Unlike patient 1 and patient 2, patient 3’s score at the extension is higher than 
at the beginning of the study with a slight increase of 10%.  
 
Role limitations due to physical health (RP) 
In this domain, all three patients reach the high score of 100% at different timepoints in the study. Patient 1 
starts out at 100% but his score decreases as the study moves forwards to a final score of 25% in the extension. 
Patient 2’s high score is reached at post-rehab. Patient 3’s score evolution shows a drastic change from post-
rehab to the extension time point from 0% to 100%.  
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Bodily Pain (BP) 
The scores in BP vary from the pre-implant to the post-rehab stage but reach a plateau for all three patients 
from post-rehab to the extension. Patient 1 and patient 2 both initially show a decrease in score at pre-
rehabilitation before increasing their score to reach this plateau. Inversely, Patient 3’s score increases at pre-
rehabilitation but is the same at pre-implant and post-rehab on.    
 
General health 
In this domain, both patient’s 1 and 2 follow a similar course: an initial decrease from pre-implant to pre-rehab 
followed by a slight increase from pre-rehab to post-rehabilitation. Both these patients’ extension scores are 
lower than initial pre-implantation score (from 65% to 40% for patient 1 and from 85% to 80% for patient 2). 
Dissimilarly, patient 3’s general health score shows a progressive increase from pre-implant to post-rehab and 
ends higher at the extension stage than at the pre-implantation stage with a final score of 50%.  
 
Mental Health (MH) 
It is important to note that the scores in the MH domain are higher than the 50% mark for all patients throughout 
the study. Patient 1 reached the lowest score at the pre-rehab timepoint with a score of 56%.  
 
Role limitation due to emotional problems (RE) 
In this domain, patient 3 has a constant score of 100%. Both patients 1 and 2 show a decrease at the pre-rehab 
timepoint (at 0% for patient 1 and at 67% for patient 2), but score at 100% for all other timepoints.  
 
Social Functioning (SF) 
The SF domain shows an increase of score for patient 2 from pre-implant to pre-rehab that stays stable forward 
on. Both patients 1 and 3’s scores, however, decrease from pre-implant to the extension stage. The social 
functioning score for all three patients stay over the 50% mark.  
 
Vitality and Fatigue (VT) 
This domain is extremely stable for all three patients. Patient 1 has the highest constant score. Patient 2’s score 
vacillates around the 50% mark. Patient 3’s score is extremely constant at 50% to 55% throughout the study.  
 
Table 3. SF-36 MCS at pre-implantation and at the extension stage for three STIMO patients. Scores in %. 
Computed using method, means and coefficients from :(57,66)  
-----------------------------------------------------------------------------------------------------------------------------------    
MCS   Patient 1 Patient 2 Patient 3  
Pre-implant 61,54 56,78 64,51 
Extension M6 68,00 57,60 56,74 
----------------------------------------------------------------------------------------------------------------------------------- 
 
Table 4. SF-36 PCS at pre-implantation and at the extension stage for three STIMO patients. Scores in %. 
Computed using method, means and coefficients from :(57,66) 
----------------------------------------------------------------------------------------------------------------------------------- 
PCS  Patient 1 Patient 2 Patient 3  
Pre-implant 34,45 30,67 15,87 
Extension M6 17,79 30,73 29,56 
----------------------------------------------------------------------------------------------------------------------------------- 
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Physical vs. mental component scores  
As previously stated, the 8 domains of the SF-36 can be divided into two categories: PCS vs. MCS. The MCS 
is shown in table 3. In comparison to the PCS in table 4, the MCS averages much higher and above 50% for 
all three patients. Although patient 3 shows a decrease in the MCS from the pre-implant to the extension, the 
variation is not drastic. In the PCS, patient 3 is the only patient whose score increases (12%). This could be in 
part due to the radical rise from 0 to 100% in RP for this patient; the RP having a positive coefficient in the 
PCS.   
 
Overall trends 
In the STIMO study, patient 1’s evolution in HRQoL improves in most domains of the SF-36 questionnaire 
except domains with a physical component (physical functioning PF and role-physical RP). His evolution 
shows particular variation in the Role Limitations due to Emotional Problems (RE) domain where a 100% 
downfall is seen from pre-implant to pre-rehab followed by a symmetrical increase of 100% from pre-rehab to 
post-rehab and a maintenance of this score in the extension.  
Patient 2’s strong domain is the BP domain in which a net improvement from 45% at pre-implant to 67,5% is 
seen. His social functioning score is also the only one that doesn’t improve in the post-rehab and extension 
stages with a loss of points from 80% to 50%.  
Patient 3 shows the least variation throughout the study. His scores stay constant with a maximal variation of 
25% from one timepoint to another in all domains. The only exception is the role physical domain where a 
clear improvement from 0% to 100% is seen in the extension stage.    
A similar trend is seen for almost all domains and patients: a decrease from pre-implant to pre-rehab followed 
by a gradual increase in score towards the extension. We could assume that further with more extension 
timepoints, the scores could exceed the pre-rehab scores for all patients, in continuum of the gradual increase 
with time post-rehabilitation. The intensive rehabilitation seems to have an important effect on all patient’s 
physical health, bringing scores down. The RE score initial decrease for patient 1 and 2 mirrors the emotional 
difficulty of adapting to a new environment and living through such an intensive rehabilitation. Although the 
study is very demanding on a physical basis, the consistency in MCS and even increase in score for patient 1 
mirrors the positive effect the study has on a mental health basis for patients who develop new hope of 
improving their locomotor function.  
 
Subjective QoL Measurements 
In STIMO, we used the WHOQOL-Bref for evaluation of our patients’ subjective QoL at multiple time points 
throughout the study: Pre-rehabilitation, Intermediate, Post-Rehabilitation, Extension 1 (corresponding to 
extension at 3 months post-rehab M3) and Extension 2 (corresponding to the extension at 6 months post-rehab 
M6). The results are illustrated in Figure 9 below, one graph corresponding to each domain. 
 
Physical domain score  
In the physical domain, a decrease is seen for patients 1 and 2 from pre-rehab to the intermediate time point, 
be it an approximately 30% decrease in physical score for patient 1 and an approximately 20% decrease for 
patient 2. Patient 3’s score does not decrease until the post-rehab timepoint (5% decrease). Patient 3 has the 
highest final score and is the only patient to score higher at the extension stage than at the entry into the trial 
at pre-rehab with a score going from 71% pre- rehab to 79%, meaning a 8% overall increase of score. Patient 
1’s scores decrease of approximately 5% from pre-rehab to the second extension, be it from 71% to 64%. 
Patient 2’s score goes from 67% to 63%, be it a variation of 4%.     
 
Psychological domain score  
The psychological domain in STIMO shows less variation than the other domains for all three patients. The 
results nearly stay constant throughout the study with less than a 5% difference from one timepoint to another 
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for each patient. Except for patient 2’s score that decreases from 67% at pre-rehab to 63% at post rehab, final 
scores at the second extension timepoint are slightly higher than initial scores at pre-rehab which shows a 
slightly favorable psychological evolution following the rehabilitation. Patient 1’s transformed psychological 
score at the 6-month extension is 83% whereas his initial score at pre-rehabilitation was 79%. Patient 3’s initial 
score is 83% and slightly improves to a score of 88% at the second extension timepoint.   
 
Social domain score  
All three patients scores decrease at post-rehab to improve in the extension. This domain shows an important 
inter-individual difference in scores. Patient 1’s scores throughout the study stay over the 75% mark whereas 
patient 3’s scores range from 58% (post-rehab) to a maximum of 75% (extension 1). Patient 2 has the overall 
lowest scores with a range from 25% to 58% and has a lower score at the 6 months extension than at the pre-
rehab timepoint. Both patients 1 and 3 show an improvement or stabilization in the social domain score from 
pre-rehab to the second extension (92% to 100% for patient 1 and stabilization at 67% for patient 3). This 
domain is the only one in which the highest possible score of 100% is reached for patient 1 at the second 
extension.  
 
Figure 9. Transformed WHOQOL-Bref scores for each domain at pre-rehab, intermediate, post rehab, 
extension 1 and extension 2 for patients 1, 2 and 3 of the STIMO study. 
-----------------------------------------------------------------------------------------------------------------------------------  
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Environment domain score 
Similar to the psychological domain, the environmental domain is one of the domains seemingly lesser 
influenced by the STIMO rehabilitation. From one timepoint to another, the maximal variation is for patient 1 
from post rehab to the first extension timepoint with an increase of 19%. Patient 3’s score is the most constant 
with a maximal 6% decrease at post-rehab followed by a max 9% increase at extension. The minimal score is 
at post-rehab after which an increase in score is seen for all three patients.  
 
Overall trends  
The following trends can be observed for all domains of the WHOQOL-Bref questionnaire in STIMO. Scores 
for all patients drop in response to the intensive rehabilitation. The rehabilitation is extremely demanding. The 
patients are far from family and friends and have to adapt to a new environment in Lausanne where they live 
for the time of the rehabilitation. This affects the social and environmental scores.  
Patient 1 has a tendency of scoring higher after the STIMO intervention than at the beginning of the trial in all 
domains except the physical domain. Patient 3’s scores are the same at pre-rehab and at the extension stage 
except for an increase in the physical domain score. Patient 2’s scores in each domain are lower at the extension 
stage than the beginning of study. His overall WHOQOL-Bref score stays constant (at 75%). Inversely, patient 
3 and patient 1’s overall scores are lower at the extension stage than at pre-rehab with a 25% decrease. [table 
6]. Most of the improvement for all three patients is seen at the extension stage showing the importance of 
such stage and a good follow up. We could expect to have a continuation of this gradual increase in WHOQOL-
Bref scores in all domains at further timepoints in the extension. The little variations in score for the social and 
environmental domains shows the difficulty of quantifying subjective QoL. The initial scores for all patients 
in all domains having all reached higher than the 50%, a ceiling effect must be expected. A variation in 
subjective QoL is harder to bring forth for STIMO chronic SCI patients.    
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Table 6. WHOQOL-Bref Overall transformed scores for STIMO patients 1,2 and 3 at pre-rehabilitation, 
intermediate, post-rehabilitation, first extension (M3) and second extension (M6).  
----------------------------------------------------------------------------------------------------------------------------------- 
     
----------------------------------------------------------------------------------------------------------------------------------- 
Functional independence  
Functional independence in the STIMO study is evaluated with the Spinal Cord Independence Measure III 
(SCIM III) at the following timepoints: pre-rehab, intermediate, post-rehab and two extensions (M3 and M6).  
The results of evolution of functional independence are illustrated in Figure 10 below. Unfortunately, the 
second extension data is not available at this time for patient 3.   
 
Figure 10. SCIM III scores for each subscale at 5 different timepoints throughout the STIMO study: pre-rehab, 
intermediate, post-rehab, first extension (M3) and second extension (M6).  
-----------------------------------------------------------------------------------------------------------------------------------
 
  
----------------------------------------------------------------------------------------------------------------------------------- 
 
ID Timepoint Raw Transformed
1 Pre-Rehab 8 75,0
1 Intermediate 7 62,5
1 Post-Rehab 8 75,0
1 Extension M3 8 75,0
1 Extension M6 6 50,0
Overall Score
ID Timepoint Raw Transformed
2 Pre-Rehab 8 75,0
2 Intermediate 6 50,0
2 Post-Rehab 6 50,0
2 Extension M3 8 75,0
2 Extension M6 8 75,0
Overall Score
ID Timepoint Raw Transformed
3 Pre-Rehab 8 75,0
3 Intermediate 8 75,0
3 Post-Rehab 7 62,5
3 Extension M3 8 75,0
3 Extension M6 6 50,0
Overall Score
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Self-Care  
In the Self-Care sub-scale of SCIM III, both patients 1 and 2 loose points from pre-rehab to the intermediate 
stage and do not regain these points further along. Patient 1’s score decreases by 2 points from 19/20 to 17/20 
whereas patient 2’s score diminishes by only 1 point. Patient 2’s scores are more variable. He is the only patient 
whose final score at the second extension is higher at 18/20 than his initial score at pre-rehab at 17/20. Note 
the score for this domain is on 20 points maximum and all three patients score higher than 16/20 at each time 
point, over the 50% mark. 
 
Respiration and sphincter management 
In this sub-scale of the SCIM III, patient 3’s score shows no evolution from one timepoint to another. Patient 
1’s final score at the second extension is one point lower than initially at pre-rehab and patient 2’s score rises 
by 2/40. All patients are over the 33/40 points placing them in the highest ¼ of respiration and sphincter 
management domain. All three patients end up with the same score at 35/40 from the first extension point on.  
 
Mobility 
In mobility, very little evolution is shown for all three patients. Patient 1’s score stays constant at 21/40 points 
throughout the trial. Patient 2’s score is almost constant at 17/40 except for a decrease at 16/40 at the 
intermediate timepoint. Patient 3’s constant score increases by one point from 18 to 19/40 at the first extension. 
Scores in mobility are very low for all patients unlike both the self-care sub-scale score and the respiration and 
sphincter management sub-scale score. All scores are less than 22/40 and patient 2 and 3’s scores are less than 
50% throughout the study with the highest reached score for patient 2 being at 17/40 and the highest score for 
patient 3 being at 19/40.  
 
Overall Trends 
The total SCIM III score in STIMO shows minimal changes. The lowest reached total score is 69% for patient 
2 at the intermediate time point and for patient 3 at post-rehab. All three patients are over the 50% bar in total 
SCIM III score showing a rather high initial functional independence score. Because this score is already very 
high in comparison to the general population, ceiling effect must be taken into consideration. As previously 
mentioned, having a significant change in score is difficult for chronic SCI patients. Evolution in all 3 sub-
scales is limited throughout the study with a maximal variation of 2-3 points from one time point to another. 
No drastic variations are observed in functional independence. 
 
STIMO patients vs. RHI general database 
The Rick Hansen Institute based in Vancouver, Canada is a non-profit organization specialized in SCI research 
and management. They work to collect data on SCI patients and have created an important database. This 
allows the comparison of results obtained in the STIMO study with results from patients following a standard 
rehabilitation. (68) As seen in figure 11 and 12 below, the comparison of SCIM III results was possible by 
selecting data in relation to individuals with ASIA C, lesion C5-C8, the same category in which STIMO 
patients fall. The RHI data for SCIM III used here includes two different timepoints: pre-rehab and community 
follow up. Wanting to compare evolution of STIMO patients to evolution of RHI patients from pre-rehab to 
the extension phase which could be paralleled with RHI community follow up, the three STIMO patients’ 
scores at pre-rehab are compared to RHI data range. As expected, STIMO patients at pre-rehab fall in the data 
range for RHI community follow up rather than in the RHI pre-rehab data range. We know STIMO patients 
are chronic, because they are all at 4 to 7 years post SCI. This comparison confirms this chronic stage and that 
STIMO individuals have already adapted to SCI: response shift has occurred. This means QoL in STIMO 
patients are more similar to the general population’s QoL scores than to QoL scores of acute SCI patients. 
(>50% scores) Because these chronic individuals have already reached higher HRQoL scores through response 
shift, the new baseline met is difficult to change: ceiling effect. Indeed, in acute patients, these two phenomena 
                                                                                           
  
21 | P a g e  
 
 
 
would be avoided. Acute SCI individuals could show more significant evolution in QoL. When comparing 
STIMO scores of SF-36 at pre-implant with RHI community follow up scores and SF-36 at the 6-month 
extension with RHI community follow up [see figure 13 and 14], STIMO individual’s evolution or rather non-
evolution in MCS and PCS scores is seen. STIMO individuals mostly stay in RHI data range from one time 
point to another and don’t show much evolution. Further time points and further patients may show progression 
in comparison to community follow up of SCI patients from RHI database.   
 
Figure 11. STIMO Patients SCIM III score at pre-
rehab timepoint in comparison to RHI data range 
with assumption of symmetry at the pre-rehab 
timepoint (selection of ASIA C, lesion C5-C8 
patients included in data) 
------------------------------------------------------------  
------------------------------------------------------------ 
Figure 13. STIMO patients SF-36 total score at 
pre-implantation in comparison to RHI data range 
with assumption of symmetry at community follow-
up (selection of ASIA C, lesion C5-C8) 
------------------------------------------------------------ 
 
Figure 12. STIMO Patients SCIM III score at pre-
rehab point in comparison to RHI data range with 
assumption of symmetry at community follow up 
(selection of ASIA C, lesion C5-C8 patients 
included in data).  
------------------------------------------------------------  
 
------------------------------------------------------------ 
Figure 14. STIMO patients SF-36 total score at 
pre-implantation in comparison to RHI data range 
with assumption of symmetry at community follow-
up (selection of ASIA C, lesion C5-C8) 
------------------------------------------------------------ 
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Discussion  
Physical Scores in Objective, Subjective QoL, and Functional Independence  
SCIM III Total vs. SF-36 PF  
In comparing the PF domain in the SF-36 [figure 7] to the Total Score for the SCIM III [figure 10], an important 
difference is seen between the two scores that are both evaluated in %. The PF domain of the SF-36’s scores 
are very low, under 35% for all three patients, even reaching 0% for patient 1 and 3 at post-rehab and patient 
1 at the second extension (M6). The PCS of objective QoL for all patient’s is very low [see table 4]. Total 
SCIM III score shows values higher than 65% for all patients at all timepoints. The evolution from one 
timepoint to another [as seen in figure 15 below], is at maximum 25% of variation for PF of the SF-36 and less 
than 10% of variation in the Total SCIM III score. In comparing HRQoL with functional independence, 
although all patients’ trajectories tend to be similar, (an increase from pre-rehab to post-rehab for patient 2 
followed by a decrease from post-rehab to the extension at 6 months; a decrease for patient 1 from pre-rehab 
to post-rehab followed by an increase from post-rehab to the extension at 6 months), HRQoL is more sensitive 
to change in the STIMO study. 
 
SCIM III Total vs. WHOQOL-Bref Physical  
The SCIM III total score, objective and clinical trial observer tested, is in concordance with the physical 
domain of WHOQOL-Bref. Maximal variation from one timepoint to another is 25% in the WHOQOL-Bref 
compared to a small variation of 4% in the total SCIM III scores [figure 16]. The trajectories in both scores 
are similar but rehabilitation in STIMO has a more important effect on subjective well-being than functional 
independence. As expected with subjective QoL evaluation, the WHOQOL-Bref is more sensitive to change 
than functional independence. Domain importance included in subjective well-being shows its effect here. The 
effect of intensive rehabilitation is observed with the decrease in scores for all patients in subjective well-being 
(at intermediate for patient 1 and patient 2 and at post-rehab for patient 3). 
 
Figure 15. SCIM III Total scores vs. SF-36 PF scores for patients 1, 2 and 3 of STIMO at pre-rehab, post-
rehab and at extension (M6).  
----------------------------------------------------------------------------------------------------------------------------------- 
 
----------------------------------------------------------------------------------------------------------------------------------- 
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Figure 16. SCIM III total scores vs. WHOQOL-Bref physical domain scores for patients 1, 2 and 3 of STIMO 
at pre-rehab, intermediate, post-rehab and at extension (M6).  
----------------------------------------------------------------------------------------------------------------------------------- 
 
----------------------------------------------------------------------------------------------------------------------------------- 
 
Figure 17. SF-36 Social Functioning (SF) scores vs. WHOQOL-Bref social domain scores for patients 1, 2 
and 3 of STIMO at pre-rehab, post-rehab and at extension (M6).  
----------------------------------------------------------------------------------------------------------------------------------- 
 
----------------------------------------------------------------------------------------------------------------------------------- 
Social and Psychological scores in objective vs. subjective QoL evaluation 
WHOQOL-Bref social domain vs. SF-36 SF and psychological domain vs. SF-36 MH 
Depending on the patient, evolutions in SF and MH scores of the SF-36 follow variable trajectories. For 
HRQoL, it is difficult to appreciate a common trend between patients for these domains [see Figure 17 and 
18]. Similar trajectories are recurrent in WHOQOL-Bref social and psychological domains. Through 
subjective QoL and domain importance, the psychological and social toll from the rehabilitation can be 
identifies by a fall of both scores at post-rehab for all patients although the impact is more or less severe 
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depending on the patient. All 3 patients’ commitment is remarkable. They moved away from their homes, 
work, family and friends in order to participate in the study as they do not come from or live in Lausanne or 
in close proximity to the training site at the CHUV. The rehabilitation program includes walking on a treadmill 
and over-ground as well as strengthening muscles and standing, enabled by task-specific EES. This intensive 
rehabilitation is repeated four to five days weekly.(55)  
 
Figure 18. SF-36 Social Functioning (SF) scores vs. WHOQOL-Bref physical domain scores for patients 1, 2 
and 3 of STIMO at pre-rehab, post-rehab and at extension (M6).  
----------------------------------------------------------------------------------------------------------------------------------- 
       
----------------------------------------------------------------------------------------------------------------------------------- 
Motor function vs. functional independence and subjective QoL 
In STIMO, locomotor function improved during rehabilitation. Without EES, progressively throughout and 
following the rehabilitation, voluntary control over paralyzed muscles was regained. The WISCI (walking 
index for spinal cord injury) and clinical evaluation by walking speed (ten-meter walking test) and endurance 
(six-minute walking test) were included to study motor function. (55) As seen in Wagner et al. 2018, post-
rehabilitation without EES, patient scores for the WISCI increase from 13 to 15 for patient 1 and from 6 to 13 
for patient 2. Clinically, both patient 1 and 2 could move from sit to stand and walk with crutches. As seen in 
figure 19.a., the ten-meter and six-minute walking test improve greatly for all patients throughout the 
rehabilitation and continue to improve post-rehabilitation (both participants continue to use EES in 
rehabilitation 1-2 times a week).(55) In comparison with SCIM III [figure 19.c] results, the significative 
advancement seen with the increase in neuromotor function is difficult to translate into functional 
independence. Variation in functional independence is extremely limited. The 6-month extension score does 
not surpass the pre-rehab score even for patient 1 who could walk a few steps without any assistive devices at 
the post-rehabilitation stage.(55) In comparing with the WHOQOL-Bref Physical scores [figure 19.b.], from 
pre-rehab to the intermediate stage, the positive evolution of endurance and walking speed is opposite to the 
initial negative evolution seen in subjective QoL. Final scores of subjective QoL at the 6-month extension 
generally do not or barely surpass scores before the rehabilitation. If the study has no significant impact on 
subjective QoL, the clinical relevance of this significant motor function improvement is put into play. 
Parallelly, the relevance of studying QoL in chronic SCI patients who already have a subjective QoL 
resembling the general population’s therefore limited space for improvement is posed.  
Because the rehabilitation stage takes such a toll on subjective QoL for all three patients and the recovery 
following the intervention follows a slow progressive upward slope, it’s difficult to evaluate at this point, 
without a longer-term follow-up the final effects of the trial. In the extension, patients tend to higher QoL. The 
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progression is still non-significant at this stage. With more data points as well as more patients, a clearer slope 
will probably be evaluable.  
 
Figure 19. a. Plot reporting changes in 6-min and 10-m walk tests for P1 (patient 1) and P2 (patient 2). Tests 
were performed without gravity-assist, following clinical guidance. For P3 (patient 3) plots report changes in 
walking distance during rehabilitation and waking speed in EES (with transparent body weight support.) 
Source:(55). b. WHOQOL-Bref scores score for patient 1,2 and 3 at pre-rehab, intermediate, post-rehab. 
Extension at 3 months, extension at 6 months. c. Total SCIM III scores for patients 1,2 and 3 at pre-rehab, 
intermediate, post-rehab. Extension at 3 months, extension at 6 months. 
-----------------------------------------------------------------------------------------------------------------------------------           
 a. 
 
 
 
 
 
b.   
   
c.  
---------------------------------------------------------------------------------------------------------------------------------- 
Conclusion 
As expected, subjective QoL is the most responsive to change in the STIMO study. This is proof that a clear 
definition of the type of QoL being evaluated is important in SCI and in all studies. Many times, subjective 
well-being is forgotten in analysis of SCI QoL even though it’s score can differ from objective QoL.  
In the STIMO study evolution, one main trend is seen in the evaluation of QoL, be it HRQoL and subjective 
QoL. Very much every aspect of QoL suffers a decrease in scores at the intermediate or post-rehab stage of 
the study, mirroring the difficulty of the STIMO study rehabilitation, especially in subjective QoL. After this 
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score drop during the rehabilitation, all patients tend to higher their QoL scores gradually yet still non-
significantly in the extension stage. Additional timepoints and patients could allow a re-evaluation of the 
evolution of objective and subjective QoL throughout the study. With time, patients would possibly further 
improve their scores and show a net improvement from pre-rehab to the further extension stages.  
Because STIMO patients are chronic SCI patients, being at 4 to 7 years post-injury, the process of adaptation 
has already occurred. STIMO patients have reached a QoL baseline similar to that of the general population. 
High scores in subjective QoL and the comparison of SCIM III and SF-36 scores with the RHI database putting 
STIMO patients at community follow up rather than pre-rehabilitation, makes for a ceiling effect. Net motor 
function improvements at this stage are difficult to translate into equal enhancement of QoL. The absence of 
significant positive impact on QoL questionnaires thus far lets us ponder the question of clinical relevance at 
this stage of SCI. However, is there a utility in considering evolution of QoL as a vital factor for clinical 
relevance in chronic SCI patients with a baseline QoL already so similar to QoL in the general population? 
If the study included acute SCI patients, their subjective QoL would not yet have undergone adaptation. Acute 
patients tend to have a much lower initial QoL score, there would be no ceiling effect. Because it is expected 
that acute patients show more enhancements of locomotor function, in parallel, QoL questionnaires should be 
able to bring to light significant improvements.  
 
Future investigations   
As already stated, a higher number of patient inclusion and a longer term follow up will allow for more data 
analysis and concretization of current trends.  
In order to change the evaluation of QoL to fit STIMO needs, the questionnaire set was added for more specific 
evaluation of SHCs. However, this questionnaire set was not analyzed in this QoL evaluation due to limited 
data and late inclusion of the questionnaires in the study. The set includes specific questionnaires for pain 
(SPA), sleep (Sleep Quality Assessment PSQI), spasticity (The Spinal Cord Injury Spasticity Evaluation Tool 
- SCI-SET), bladder and bowel control problems (clinical evaluation in bladder function and the Neurogenic 
Bowel Dysfunction Score), and sexuality (International Index of Erectile Dysfunction). A thorough follow-up 
in the extension stage has been put together with a fill at home e-survey including all these QoL questionnaires. 
By separating the analysis of each important SHCs that effect QoL in chronic SCI, trends and evolution could 
be more sensible to variation and show significant improvements.  
The effect of certain variables in STIMO on QoL could also be further detailed. For instance, development of 
muscular tissue and improvement of orthostasis with a better regulated blood pressure with rehabilitation and 
verticalization can have positive effects on health and SCI morbidity (67) and effects individuals’ QoL to a 
certain measure.  
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